These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33044676)

  • 21. HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management.
    Atta MG; Lucas GM; Fine DM
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):365-71. PubMed ID: 18588500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
    Kopp JB; Heymann J; Winkler CA
    Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and natural history of HIV-associated nephropathy.
    Atta MG
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):52-8. PubMed ID: 20005489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 and kidney cells: better understanding of viral interaction.
    Mikulak J; Singhal PC
    Nephron Exp Nephrol; 2010; 115(2):e15-21. PubMed ID: 20407278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa.
    Han TM; Naicker S; Ramdial PK; Assounga AG
    Kidney Int; 2006 Jun; 69(12):2243-50. PubMed ID: 16672914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.
    Sola-Del Valle DA; Mohan S; Cheng JT; Paragas NA; Sise ME; D'Agati VD; Barasch J
    Nephrol Dial Transplant; 2011 Jul; 26(7):2387-90. PubMed ID: 21555394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress in HIV-associated nephropathy.
    Wyatt CM; Meliambro K; Klotman PE
    Annu Rev Med; 2012; 63():147-59. PubMed ID: 21888512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
    Waziri B; Raji YE; Ekrikpo UE; Naicker S
    J Nephrol; 2023 May; 36(4):1119-1134. PubMed ID: 36510118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-associated nephropathy: a brief review.
    Lu TC; Ross M
    Mt Sinai J Med; 2005 May; 72(3):193-9. PubMed ID: 15915314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population.
    Ikpeme EE; Ekrikpo UE; Akpan MU; Ekaidem SI
    Pan Afr Med J; 2012; 11():13. PubMed ID: 22368756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates on HIV and Kidney Disease.
    Cervantes CE; Atta MG
    Curr HIV/AIDS Rep; 2023 Apr; 20(2):100-110. PubMed ID: 36695948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
    Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
    PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating fibroblast growth factor-2 precipitates HIV nephropathy in mice.
    Das JR; Jerebtsova M; Tang P; Li J; Yu J; Ray PE
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34308967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmembrane TNF-
    Li J; Das JR; Tang P; Han Z; Jaiswal JK; Ray PE
    J Am Soc Nephrol; 2017 Mar; 28(3):862-875. PubMed ID: 27811066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-associated nephropathy.
    Winston J; Klotman PE
    Mt Sinai J Med; 1998 Jan; 65(1):27-32. PubMed ID: 9458681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-Associated Nephropathy in Africa: Pathology, Clinical Presentation and Strategy for Prevention.
    Husain NE; Ahmed MH; Almobarak AO; Noor SK; Elmadhoun WM; Awadalla H; Woodward CL; Mital D
    J Clin Med Res; 2018 Jan; 10(1):1-8. PubMed ID: 29238427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 and HIV-Associated Nephropathy 25 Years Later.
    Wyatt CM; Klotman PE
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S20-4. PubMed ID: 17699507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-associated nephropathy: virologic issues related to renal sclerosis.
    Kimmel PL
    Nephrol Dial Transplant; 2003 Aug; 18 Suppl 6():vi59-63. PubMed ID: 12953044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.
    Papeta N; Sterken R; Kiryluk K; Kalyesubula R; Gharavi AG
    J Mol Med (Berl); 2011 May; 89(5):429-36. PubMed ID: 21221512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.